IND

(redirected from Investigational New Drug)
Also found in: Dictionary, Thesaurus, Medical, Financial, Acronyms, Wikipedia.

IND

On drawings, abbr. for “industrial.”
McGraw-Hill Dictionary of Architecture and Construction. Copyright © 2003 by McGraw-Hill Companies, Inc.
References in periodicals archive ?
The US Food and Drug Administration (FDA) has granted investigational new drug approval (IND) to France-based Sensorion to proceed with SENS-401, based on preclinical data and clinical development plan, it was reported yesterday.
BioArctic AB (STO:BIOA B), a Swedish research-based biopharmaceutical company, announced on Monday the receipt by AbbVie Inc (NYSE:ABBV) of approval from the US Food and Drug Administration (FDA) of the Investigational New Drug (IND) application for ABBV-0805.
In addition, these same types of trials that are privately sponsored are covered if they are regulated by the FDA under an investigational new drug (INDA) application or if they meet requirements to be INDA exempt.
Investigational new drugs, including biologic drugs, will face new safety reporting requirements designed to increase timeliness as well as decrease unnecessary reporting of events not likely to be causal.
Novavax plans to submit an investigational new drug application to the Food and Drug Administration in mid-2007 to begin human clinical trials with the vaccine.
BioMS Medical Corp (TSX: MS), Edmonton, Canada, a leading developer of products for the treatment of multiple sclerosis (MS), has received clearance from the United States Food and Drug Administration (FDA) of its Investigational New Drug Application (IND) for the initiation of a pivotal phase III clinical trial to investigate the use of MBP8298 as a treatment for patients with secondary progressive MS.
The letter also charged that the firm's Web sitewww.alfredtrsapsemd.compromoted the implants and said they were "safe and effective in treating a variety of illnesses," which was in violation of FDA policy which says biological products may generally be distributed for clinical use in humans only if the sponsor has an investigational new drug application in effect.
He was successful in assisting sponsors in filing Investigational New Drug (IND) applications for heterogeneous botanical products with the FDA Center for Drug Evaluation and Research (CDER).
A final rule issued by FDA simplifying requirements for investigational new drug exports prohibits transshipment of drugs from a "listed" country to an "unlisted" country where the drug does not have market authorization, but otherwise includes few changes over the proposed rule issued in 2002.
In the U.S., an investigational new drug application (IND) is submitted to the Food and Drug Administration seeking permission to begin the heavily regulated process of clinical testing in human subjects.
There is little on quality assurance and regulation, such as the investigational new drug application process and current good manufacturing practice, although good clinical practice is mentioned.

Full browser ?